Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Taiwan Speciality Chemicals Corporation (4772) AI Stock Analysis

TW:4772

Taiwan Speciality Chemicals Corporation

(TPEx:4772)

Select Model
Rating:68Neutral
Price Target:TWD 210.00â–¼(-3.67% Downside)
Action:initiatedcoverage
Date:11/10/26

Strong financial performance is the primary support for the score, led by rapid growth, high margins, and positive free cash flow. This is offset by a pronounced technical downtrend and relatively expensive valuation, producing an overall score of 68.

Positive Factors
Revenue GrowthThe sharp 2025 revenue increase indicates substantially stronger business activity and customer demand than the prior year. If this higher revenue base is sustained, it can support continued operating leverage, strengthen earnings capacity, and provide greater resources for future investment.
Negative Factors
Higher LeverageThe substantial increase in borrowing has reduced balance-sheet flexibility compared with the company’s near-zero leverage position in earlier years. Higher debt can increase financing obligations and make the business more sensitive to weaker industry conditions, limiting room for discretionary investment.

Taiwan Speciality Chemicals Corporation (4772) vs. SPDR S&P 500 ETF (SPY)

-40%-30%-20%-10%0%10%20%30%40%TW:4772-23.36%SPY+14.28%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
TWD 32.19B
Dividend Yield
1.38%
Average Volume (3M)
783.90K
Price to Earnings (P/E)
38.0
Beta (1Y)
1.36
Revenue Growth
163.69%
EPS Growth
66.91%
Country
TW
Employees
123
Sector
General
Sector Strength
55
Industry
Chemicals - Specialty

Taiwan Speciality Chemicals Corporation Business Overview & Revenue Model

Company Description

Taiwan Speciality Chemicals Corporation is a Taiwanese enterprise dedicated to the production and supply of specialized electronic-grade gases and chemicals. Its product portfolio features key offerings such as disilane, trisilane, and a variety of r...

Taiwan Speciality Chemicals Corporation Financial Statement Overview

Summary

Strong revenue and net income growth, high profitability, and substantial free cash flow support the score. The main deductions reflect declining margins, materially higher leverage, and weaker operating cash-flow coverage.

Income Statement

84Very Positive

Balance Sheet

78Positive

Cash Flow

82Very Positive
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue3.26B1.99B873.96M553.52M532.28M515.67M
Gross Profit1.64B1.03B462.75M210.23M263.87M261.17M
EBITDA1.52B971.33M477.44M258.57M331.69M329.50M
Net Income888.64M620.07M385.59M155.65M207.97M194.44M
Balance Sheet
Total Assets8.52B7.22B3.39B1.84B1.80B1.70B
Cash, Cash Equivalents and Short-Term Investments2.48B2.01B1.73B154.77M114.60M57.78M
Total Debt2.69B2.09B0112.00K060.00M
Total Liabilities3.91B2.71B153.23M83.76M105.90M119.81M
Stockholders Equity3.70B3.72B3.23B1.76B1.69B1.58B
Cash Flow
Free Cash Flow428.02M730.86M483.19M133.43M206.29M302.24M
Operating Cash Flow1.47B946.94M528.89M234.64M301.04M344.56M
Investing Cash Flow-2.20B-1.38B-1.05B-100.22M-93.88M-42.35M
Financing Cash Flow2.26B1.69B1.09B-94.25M-150.34M-270.17M

Taiwan Speciality Chemicals Corporation Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

TW:4772 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
TW:4770TW:477069NeutralTWD 23.63B26.15―1.95%-5.30%-14.35%
TW:5234TW:523469NeutralTWD 27.01B31.38―2.48%11.98%23.72%
TW:4772TW:477268NeutralTWD 32.12B37.98―1.38%163.69%66.91%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
TW:1711TW:171144NeutralTWD 21.66B270.82―0.80%-2.22%33.13%

* General Sector Average

Performance Comparison

0%200%400%600%TW:4772TW:1711TW:3595TW:4770TW:5234TW:6826Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
TW:4772 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
TW:4772Taiwan Speciality Chemicals Corporation218.00-77.33-26.19%
TW:1711Everlight Chemical Industrial Corporation37.4018.4697.50%
TW:3595Alliance Material Co., Ltd.642.00371.28137.15%
TW:4770Allied Supreme Corp308.0087.2939.55%
TW:5234Daxin Materials Corporation262.00-76.79-22.67%
TW:6826Taiwan Puritic Corp.342.50-53.51-13.51%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 10, 2026